{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T06:07:39Z","timestamp":1788934059768,"version":"build-2803163510"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Young and middle-aged patients with breast cancer receiving particle therapy commonly experience elevated Fear of Progression (FoP). Evidence for the effectiveness of acceptance and commitment therapy (ACT) in this population remains limited. This study evaluated the effects of ACT on FoP and on related psychological outcomes, namely psychological flexibility and psychological distress.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This parallel-group randomized controlled trial was conducted at an oncology hospital in Shanghai, China, and enrolled participants between June and August 2025. A total of 108 young and middle-aged patients with breast cancer and elevated FoP (Fear of Progression Questionnaire\u2013Short Form, FoP-Q-SF, \u226534) were randomly assigned in a 1:1 ratio to the intervention group (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f54) or control group (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f54). The intervention group received five group-based sessions (90\u2013120\u202fmin each) over 2.5\u202fweeks, covering acceptance, cognitive defusion, present-moment awareness, self-as-context, values clarification, and committed action, whereas the control group received usual care. Outcomes were assessed at baseline, immediately after the intervention, and at 1- and 3-month follow-ups. Intention-to-treat analyses used generalized estimating equations adjusted for cancer stage, age, and education. Sensitivity analyses used multiple imputation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The overall attrition was 12%, and no intervention-related adverse events were identified. Compared with the control group, the intervention group showed greater reductions in FoP at all post-intervention time points (T1\u2013T3, all\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001) and in psychological distress at all follow-ups (T1\u2013T3, all\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05). These findings were robust in sensitivity analyses. The effect on psychological flexibility emerged later, reaching statistical significance at T3 (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.037) and remaining significant in the sensitivity analysis (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.046).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Acceptance and commitment therapy reduced FoP and psychological distress in this population, with a delayed effect on psychological flexibility. These findings support integrating structured, group-based ACT into routine care during particle therapy. Multicenter trials with longer follow-up are needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Chinese Clinical Trial Registry Identifier: ChiCTR2500104142.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1920215","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:58:41Z","timestamp":1788933521000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of acceptance and commitment therapy on fear of progression in young and middle-aged patients with breast cancer receiving particle therapy: a randomized controlled trial"],"prefix":"10.3389","volume":"14","author":[{"given":"Aoxing","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Nursing, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai Key Laboratory of Radiation Oncology","place":["Shanghai, China"]},{"name":"Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nursing, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai Key Laboratory of Radiation Oncology","place":["Shanghai, China"]},{"name":"Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuman","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nursing, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai Key Laboratory of Radiation Oncology","place":["Shanghai, China"]},{"name":"Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Nursing, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai Key Laboratory of Radiation Oncology","place":["Shanghai, China"]},{"name":"Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nursing, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai Key Laboratory of Radiation Oncology","place":["Shanghai, China"]},{"name":"Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Nursing, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai Key Laboratory of Radiation Oncology","place":["Shanghai, China"]},{"name":"Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Nursing, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai Key Laboratory of Radiation Oncology","place":["Shanghai, China"]},{"name":"Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.46234\/ccdcw2025.055","volume":"7","author":"Bao","year":"2025","journal-title":"China CDC Wkly"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3322\/caac.21863","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"102357","DOI":"10.1016\/j.ejon.2023.102357","article-title":"Factors associated with psychosocial adjustment in newly diagnosed young to middle-aged women with breast cancer: a cross-sectional study","volume":"65","author":"Zhang","year":"2023","journal-title":"Eur J Oncol Nurs"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/instruments7010009","article-title":"A beam monitor for ion beam therapy based on HV-CMOS pixel detectors","volume":"7","author":"Dierlamm","year":"2023","journal-title":"Instruments"},{"key":"ref6","volume-title":"Simulation of Proton and Carbon-12 Ion Beam for Tumor\/Cancer Treatment","author":"Kanishka","year":"2024"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ctrv.2010.01.004","article-title":"New developments in arc radiation therapy: a review","volume":"36","author":"Palma","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"23379","DOI":"10.18632\/aging.103932","article-title":"Radiation-induced skin injury: pathogenesis, treatment, and management","volume":"12","author":"Yang","year":"2020","journal-title":"Aging"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"101898","DOI":"10.1016\/j.ejon.2021.101898","article-title":"Factors affecting anxiety and depression in young breast cancer survivors undergoing radiotherapy","volume":"50","author":"Kim","year":"2021","journal-title":"Eur J Oncol Nurs"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3969\/j.issn.1009-8399.2021.09.002","article-title":"Qualitative study on psychological experience of cancer patients during proton and heavy ion radiation therapy","volume":"21","author":"Zhu","year":"2021","journal-title":"Shanghai Nurs"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"102617","DOI":"10.1016\/j.ejon.2024.102617","article-title":"The trajectories of psychosocial adjustment among young to middle-aged women with breast cancer: a prospective longitudinal study","volume":"71","author":"Zhang","year":"2024","journal-title":"Eur J Oncol Nurs"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e6339","DOI":"10.1002\/pon.6339","article-title":"A randomized clinical trial: efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression","volume":"33","author":"Alimolk","year":"2024","journal-title":"Psychooncology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1007\/s00520-016-3272-5","article-title":"From normal response to clinical problem: definition and clinical features of fear of cancer recurrence","volume":"24","author":"Lebel","year":"2016","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1055\/s-2003-40094","article-title":"Fear of progression in patients with cancer, diabetes mellitus and chronic arthritis","volume":"42","author":"Dankert","year":"2003","journal-title":"Rehabil"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2794408","DOI":"10.1155\/2022\/2794408","article-title":"Investigation of factors influencing the fear of Cancer recurrence in breast Cancer patients using structural equation modeling: a cross-sectional study","volume":"2022","author":"Guo","year":"2022","journal-title":"Int J Clin Pract"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1400695","DOI":"10.3389\/fpsyg.2024.1400695","article-title":"Fear of disease progression, self-management efficacy, and family functioning in patients with breast cancer: a cross-sectional relationship study","volume":"15","author":"Zhuang","year":"2024","journal-title":"Front Psychol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/cncr.33921","article-title":"Trajectories of fear of cancer recurrence in young breast cancer survivors","volume":"128","author":"Schapira","year":"2022","journal-title":"Cancer"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.4143\/crt.2021.835","article-title":"Fear of cancer recurrence and its negative impact on health-related quality of life in long-term breast cancer survivors","volume":"54","author":"Tran","year":"2022","journal-title":"Cancer Res Treat"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/pon.5265","article-title":"Impact of fear of cancer recurrence on survival among lymphoma patients","volume":"29","author":"Kim","year":"2020","journal-title":"Psychooncology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1002\/pon.5497","article-title":"Trajectory of fear of cancer recurrence and beliefs and rates of medication adherence in patients with breast cancer","volume":"29","author":"Shim","year":"2020","journal-title":"Psychooncology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/pon.1481","article-title":"Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors","volume":"18","author":"Mehnert","year":"2009","journal-title":"Psychooncology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00520-025-09503-9","article-title":"Coping strategies for fear of cancer recurrence among breast cancer survivors: a systematic review and thematic synthesis of qualitative studies","volume":"33","author":"Mardani","year":"2025","journal-title":"Support Care Cancer"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"6720","DOI":"10.3390\/curroncol30070493","article-title":"Fear of cancer recurrence and coping strategies among prostate cancer survivors: a qualitative study","volume":"30","author":"Mardani","year":"2023","journal-title":"Curr Oncol"},{"key":"ref24","first-page":"373","volume-title":"ACT Made Simple: An Easy-to-Read Primer on Acceptance and Commitment Therapy","author":"Harris","year":"2019"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brat.2005.06.006","article-title":"Acceptance and commitment therapy: model, processes and outcomes","volume":"44","author":"Hayes","year":"2006","journal-title":"Behav Res Ther"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/cncr.32518","article-title":"Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: a 3-arm pilot randomized controlled trial","volume":"126","author":"Johns","year":"2020","journal-title":"Cancer"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s00520-023-08179-3","article-title":"Real-world evaluation of an acceptance and commitment therapy-based group programme for breast cancer survivors with fear of cancer recurrence","volume":"31","author":"Sinclair","year":"2023","journal-title":"Support Care Cancer"},{"key":"ref28","first-page":"16","article-title":"Re-partitioning population age group and its implications","volume":"41","author":"Luo","year":"2017","journal-title":"Popul Res Policy Rev"},{"key":"ref29","volume-title":"Breast Tumours","year":"2019"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1037\/17335-000","volume-title":"Acceptance and Commitment Therapy: The Process and Practice of Mindful Change","author":"Hayes","year":"2012"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"274","DOI":"10.13109\/zptm.2006.52.3.274","article-title":"Fear of progression in breast cancer patients--validation of the short form of the fear of progression questionnaire (FoP-Q-SF)","volume":"52","author":"Mehnert","year":"2006","journal-title":"Z Psychosom Med Psychother"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3761\/j.issn.0254-1769.2015.12.021","article-title":"Reliability and validity of Chinese version of fear of progression questionnaire-short form for cancer patients","volume":"50","author":"Wu","year":"2015","journal-title":"Chin J Nurs"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.beth.2011.03.007","article-title":"Preliminary psychometric properties of the acceptance and action questionnaire-II: a revised measure of psychological inflexibility and experiential avoidance","volume":"42","author":"Bond","year":"2011","journal-title":"Behav Ther"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3969\/j.issn.1000-6729.2013.11.014","article-title":"Reliability and validity of the Chinese version of the acceptance and action questionnaire-second edition (AAQ-II) in college students","volume":"27","author":"Cao","year":"2013","journal-title":"Chin Ment Health J"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/(sici)1097-0142(19980515)82:10<1904::aid-cncr13>3.0.co;2-x","article-title":"Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study","volume":"82","author":"Roth","year":"1998","journal-title":"Cancer"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11670-011-0054-y","article-title":"Validation and reliability of distress thermometer in chinese cancer patients","volume":"23","author":"Tang","year":"2011","journal-title":"Chin J Cancer Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/ede.0b013e3181caeb90","article-title":"To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health","volume":"21","author":"Hubbard","year":"2010","journal-title":"Epidemiology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"102862","DOI":"10.1016\/j.ejon.2025.102862","article-title":"Acceptance and commitment therapy effectiveness for fear of cancer recurrence: a systematic review and meta-analysis","volume":"76","author":"Yuyan","year":"2025","journal-title":"Eur J Oncol Nurs"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1200\/JCO.19.00572","article-title":"Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis","volume":"37","author":"Tauber","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/pon.3659","article-title":"Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence","volume":"24","author":"Butow","year":"2015","journal-title":"Psychooncology"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"102460","DOI":"10.1016\/j.ejon.2023.102460","article-title":"The association between metacognition, coping style and fear of cancer recurrence among postmastectomy patients: a cross sectional study","volume":"67","author":"Zhang","year":"2023","journal-title":"Eur J Oncol Nurs Off J Eur Oncol Nurs Soc"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1037\/0033-295x.101.1.34","article-title":"Ironic processes of mental control","volume":"101","author":"Wegner","year":"1994","journal-title":"Psychol Rev"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/pon.3890","article-title":"An acceptance and commitment therapy (ACT) group intervention for cancer survivors experiencing anxiety at re-entry","volume":"25","author":"Arch","year":"2016","journal-title":"Psychooncology"},{"key":"ref44","first-page":"351","volume-title":"Mindfulness-Based Cognitive Therapy for Depression: A New Approach to Preventing Relapse","author":"Segal","year":"2002"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00520-024-09126-6","article-title":"Efficacy of acceptance and commitment therapy on psychological rehabilitation in cancer patients treated with proton and heavy ion therapy: a non-randomized controlled trial","volume":"33","author":"Qin","year":"2025","journal-title":"Support Care Cancer"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brat.2017.01.013","article-title":"Increasing valued behaviors precedes reduction in suffering: findings from a randomized controlled trial using ACT","volume":"91","author":"Gloster","year":"2017","journal-title":"Behav Res Ther"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/17437199.2023.2261518","article-title":"Acceptance and commitment therapy processes and their association with distress in cancer: a systematic review and meta-analysis","volume":"18","author":"Fawson","year":"2024","journal-title":"Health Psychol Rev"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1046\/j.1365-2648.2003.02938.x","article-title":"Psychological distress: concept analysis","volume":"45","author":"Ridner","year":"2004","journal-title":"J Adv Nurs"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s13187-012-0404-6","article-title":"Patient distress and emotional disclosure: a study of chinese cancer patients","volume":"28","author":"Wei","year":"2013","journal-title":"J Cancer Educ Off J Am Assoc Cancer Educ"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"368","DOI":"10.5993\/AJHB.41.4.1","article-title":"Coping strategies and benefit-finding in the relationship between non-disclosure and depressive symptoms among breast cancer survivors in China","volume":"41","author":"Lee","year":"2017","journal-title":"Am J Health Behav"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e269954","DOI":"10.1001\/jamanetworkopen.2026.9954","article-title":"Family disclosure of a cancer diagnosis to patients","volume":"9","author":"Hu","year":"2026","journal-title":"JAMA Netw Open"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"E436","DOI":"10.1097\/NCC.0000000000000983","article-title":"Evaluation of a nurse-led aftercare intervention for patients with head and neck cancer treated with radiotherapy and cisplatin or cetuximab","volume":"45","author":"Braat","year":"2022","journal-title":"Cancer Nurs"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1920215\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:58:45Z","timestamp":1788933525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1920215\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":52,"alternative-id":["10.3389\/fpubh.2026.1920215"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1920215","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"article-number":"1920215"}}